PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

Summary

The purpose of this study is to gain understanding of how PET-MR (positron emission tomography-magnetic resonance imaging) using the substance 18F-DCFPyL (PyL) may help in diagnosing prostate cancer and in determining the stage of prostate cancer before surgery.

Timeline

Start

2018-06-08

Primary completion

2026-05-01

Completion

2026-06-01

Publications

• Li EV, Schaeffer EM, Ramesh Kumar SKS, Zhou R, Yang XJ, Mana-Ay M, Vescovo M, Ho A, Keeter MK, Carr J, Casalino D, Kocherginsky M, Patel HD, Ross AE, Savas H. Utility of 18F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomy. Eur J Nucl Med Mol Imaging. 2025 Jun;52(7):2335-2342. doi: 10.1007/s00259-025-07133-1. Epub 2025 Feb 10.

Drugs

Indications